Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cvitkovic

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pathologie-Biologie|January 6, 2001
[40 years of progress in chemotherapy]F Cvitkovic-Bertheault
In Vivo (Athens, Greece)|May 7, 2005
Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculographyM F Pichon, F Cvitkovic, K Hacene, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2007
A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5 FU2 + irinotecan or LV5 FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le CancerY Bécouarn, P Senesse, S Thézenas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2001
High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II studyD Peiffert, M Giovannini, M Ducreux, et al.
Bulletin Du Cancer|October 15, 1998
[Mitomycin-vinorelbine combination as second-line chemotherapy in metastatic cancer of the breast]H Bourgeois, F Turpin, M Bouchada, et al.
British Journal of Cancer|January 13, 2006
'A phase II study of oral uracil/ftorafur (UFT) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer'J Bennouna, H Perrier, B Paillot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2011
Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumabD Malka, V Boige, N Jacques, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: a French cooperative studyD Peiffert, J F Seitz, P Rougier, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pathologie-Biologie|January 6, 2001
[40 years of progress in chemotherapy]F Cvitkovic-Bertheault
In Vivo (Athens, Greece)|May 7, 2005
Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculographyM F Pichon, F Cvitkovic, K Hacene, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2007
A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5 FU2 + irinotecan or LV5 FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le CancerY Bécouarn, P Senesse, S Thézenas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2001
High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II studyD Peiffert, M Giovannini, M Ducreux, et al.
Bulletin Du Cancer|October 15, 1998
[Mitomycin-vinorelbine combination as second-line chemotherapy in metastatic cancer of the breast]H Bourgeois, F Turpin, M Bouchada, et al.
British Journal of Cancer|January 13, 2006
'A phase II study of oral uracil/ftorafur (UFT) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer'J Bennouna, H Perrier, B Paillot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2011
Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumabD Malka, V Boige, N Jacques, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: a French cooperative studyD Peiffert, J F Seitz, P Rougier, et al.
Pageof 1